课题基金 / 基金详情

Research Training: Chronic Non-communicable CVDs and Comorbidities in Peru

Research Training: Chronic Non-communicable CVDs and Comorbidities in Peru
研究培训:秘鲁的慢性非传染性心血管疾病和合并症
批准号:
10483128
负责人:
Victor G. Davila-Roman
金额:
$24.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-07-31

项目摘要

项目成果

Victor G. Davila-Roman的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 MPI:De las Fuentes,Lisa;Davila-Roman,Victor G.;Málaga,德语;Hartinger,Stella D43项目标题:“研究培训:秘鲁的慢性非传染性心血管疾病和共病” 项目开始/结束时间:2021年9月1日至2026年8月31日 慢性心血管疾病(CVD)是全球和秘鲁并购的主要原因。除 常见的心血管疾病危险因素、社会因素等社会经济地位低和环境暴露进一步 造成慢性心血管疾病负担。在非传染性疾病中,高血压患病率很高 由于知晓率低,治疗和控制是一个重要的卫生保健缺口,导致 秘鲁的心血管疾病负担。这份D43培训补助金申请代表了美国与美国之间的合作 调查人员(圣路易斯的华盛顿大学和巴尔的摩的约翰·霍普金斯大学)和 秘鲁调查人员(利马Peruana Cayetano Heredia大学、国家大学 AltiPlano de Puno,AB Prisma在利马和Puno)。D43培训计划将利用现有研究 在秘鲁开展项目和基础设施,培训秘鲁科学家和卫生专业人员治疗慢性非传染性疾病/心血管疾病。 我们的组织已经成功地获得了赠款支持(即NIH、盖茨基金会);然而,有限的 进行和领导非传染性疾病/心血管疾病研究的秘鲁调查人员的数量是实现 实施有效和可持续的非传染性疾病/心血管疾病研究计划。拟议的培训方案将 在五年内为14名学员提供支持(学费、津贴、研究经费):8名硕士、4名博士和2名 秘鲁博士后实习生和/或初级教员。这一结构化计划的目标是开发 受训人员在慢性心血管疾病、中风、实施科学和环境领域的研究生涯 曝光;由国际知名的多学科教师提供指导和支持 专业知识;并为职业发展和参与研究项目提供机会。这个 该计划将提供强化培训机会,并在一系列科学学科和 与实现研究独立性相关的技能。这一计划的长期目标是建立一个可持续的 和协作研究-培训基础设施,以培养秘鲁研究科学家能够设计 以及执行针对未得到满足的医疗保健需求的干预措施,包括将循证医学 秘鲁改善公共卫生的干预措施以及有效政策的实施和传播。 此应用程序响应PAR-18-901的合作机构,包括NHLBI(HTN/CVD)、Fogarty 国际中心(全球卫生和LMIC)、国家老龄研究所(NCDs包括CVD/HTN)、国家 神经疾病和中风研究所(中风)和国家环境卫生科学研究所 (环境暴露是非传染性疾病/心血管疾病的风险因素)。这项D43培训计划的最终目标是 双重:1)为优秀的初级调查人员配备必要的专业知识,以解决具有挑战性的问题 秘鲁慢性非传染性疾病/心血管疾病负担带来的问题;和2)完成 项目管理和领导力从美国到秘鲁的MPI、教职员工和机构,到D43年级5。
英文摘要
PROJECT SUMMARY MPIs: de las Fuentes, Lisa; Davila-Roman, Victor G.; Málaga, German; Hartinger, Stella D43 Project Title: “Research Training: Chronic Non-communicable CVDs and Comorbidities in Peru” Project start / end: 9/1/2021-8/31/2026 Chronic cardiovascular disease (CVD) is the leading cause of M&M worldwide and in Peru. In addition to the usual CVD risk factors, social factors such a low socioeconomic status and environmental exposure further contribute to chronic CVD burden. Among non-communicable diseases (NCDs), high prevalence of hypertension with low rates of awareness, treatment and control represent an important health care gap that contributes to CVD burden in Peru. This application for D43 Training Grant represents a collaboration between US investigators (Washington University in St. Louis and Johns Hopkins University in Baltimore) and Peruvian investigators (Universidad Peruana Cayetano Heredia in Lima, Universidad Nacional del Altiplano de Puno, AB PRISMA in Lima and Puno). The D43 training program will leverage existing research projects and infrastructure in Peru to train Peruvian scientists and health professionals in chronic NCDs/CVD. Our group has been successful in securing grant support (i.e., NIH, Gates Foundation); however, the limited number of Peruvian investigators conducting and leading NCD/CVD studies represents a significant barrier to implementing an effective and sustainable NCD/CVD research program. The proposed training program will provide support (tuition, stipend, research funds) for 14 trainees over five years: 8 master’s, 4 PhD, and 2 postdoctoral Peruvian trainees and/or junior faculty. The objectives of this structured program are to develop the research careers of trainees in the areas of chronic CVD, stroke, implementation science, and environmental exposure; to provide mentoring and support by an internationally renowned faculty with multidisciplinary expertise; and to provide opportunities for career advancement and engagement in research projects. The program will provide intensive training opportunities and build capacity in a range of scientific disciplines and skills relevant to achieving research independence. The long-term goal of this program is to build a sustainable and collaborative research-training infrastructure to develop Peruvian research scientists capable of designing and executing interventions addressing unmet healthcare needs, including the translation of evidence-based interventions and the implementation and dissemination of effective policies to improve public health in Peru. This application is responsive to partnering institutions of PAR-18-901 including the NHLBI (HTN/CVD), Fogarty International Center (global health and LMIC), National Institute of Aging (NCDs including CVD/HTN), National Institute of Neurological Disorders and Stroke (stroke), and National Institutes of Environmental Health Sciences (environmental exposure as risk factors for NCDs/CVD). The ultimate goals of this D43 training program are twofold: 1) to equip outstanding junior investigators with the necessary expertise to solve challenging problems presented by the burden of chronic NCDs/CVD in Peru; and 2) to complete a full transition of program administration and leadership from the US to Peruvian MPIs, faculty, and institutions by D43 Year 5.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")
  • 批准号:
    10717478
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2023
  • 负责人:
    Victor G. Davila-Roman
  • 依托单位:
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting
  • 批准号:
    10618374
  • 项目类别:
  • 资助金额:
    $79.69万
  • 财政年份:
    2022
  • 负责人:
    Victor G. Davila-Roman
  • 依托单位:
Washington University SummeR reseArch DIversity ProgrAm iN Cardiovascular Disease & HEmatology (RADIANCE)
  • 批准号:
    10619007
  • 项目类别:
  • 资助金额:
    $16.61万
  • 财政年份:
    2022
  • 负责人:
    Victor G. Davila-Roman
  • 依托单位:
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting
  • 批准号:
    10426758
  • 项目类别:
  • 资助金额:
    $63.59万
  • 财政年份:
    2022
  • 负责人:
    Victor G. Davila-Roman
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: